NIR-II Light-Driven Genetically Engineered Exosome Nanocatalysts for Efficient Phototherapy against Glioblastoma
Journal of the American Chemical Society · 05.06.2024 · 146 (22) · 15251-15263
DOI: 10.1021/jacs.4c02530 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Chemical Society, online erschienen am 23.05.2024. Verfasst von Xueyang Fang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Shenzhen Institute of Translational Medicine, Shenzhen Second People's Hospital, The First Affiliated Hospital of Shenzhen University, Shenzhen Unive…. Hauptthemen laut MEDLINE: Glioblastoma, Infrared Rays, Exosomes, Phototherapy. Die Arbeit wurde bisher 66-mal zitiert (Crossref) und nennt 57 Literaturangaben. Gefördert von: Science and Technology Foundation of Shenzhen City, Basic and Applied Basic Research Foundation of Guangdong Province, Sanming Project of Medicine in Shenzen Municipality.
Abstract (Originalsprache)
Glioblastoma (GBM) poses a significant therapeutic challenge due to its invasive nature and limited drug penetration through the blood-brain barrier (BBB). In response, here we present an innovative biomimetic approach involving the development of genetically engineered exosome nanocatalysts (Mn@Bi2Se3@RGE-Exos) for efficient GBM therapy via improving the BBB penetration and enzyme-like catalytic activities. Interestingly, a photothermally activatable multiple enzyme-like reactivity is observed in such a nanosystem. Upon NIR-II light irradiation, Mn@Bi2Se3@RGE-Exos are capable of converting hydrogen peroxide into hydroxyl radicals, oxygen, and superoxide radicals, providing a peroxidase (POD), oxidase (OXD), and catalase (CAT)-like nanocatalytic cascade. This consequently leads to strong oxidative stresses to damage GBM cells. In vitro, in vivo, and proteomic analysis further reveal the potential of Mn@Bi2Se3@RGE-Exos for the disruption of cellular homeostasis, enhancement of immunological response, and the induction of cancer cell ferroptosis, showcasing a great promise in anticancer efficacy against GBM with a favorable biosafety profile. Overall, the success of this study provides a feasible strategy for future design and clinical study of stimuli-responsive nanocatalytic medicine, especially in the context of challenging brain cancers like GBM.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Shenzhen Institute of Translational Medicine, Shenzhen Second People's Hospital, The First Affiliated Hospital of Shenzhen University, Shenzhen University Medical School, College of Materials Science and Engineering, Sh…
- Faculty of Synthetic Biology, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen 518055, China.
- Guangzhou Municipal and Guangdong Provincial Key Laboratory of Molecular Target & Clinical Pharmacology, the NMPA and State Key Laboratory of Respiratory Disease, School of Pharmaceutical Sciences, Guangzhou Medical Uni…
- State Key Laboratory of Fine Chemicals, Dalian University of Technology, Dalian 116024, China.
ORCID-Profile: Mingle Li, Xiaojun Peng, Bin Zhang
Förderung
- Science and Technology Foundation of Shenzhen City
- Basic and Applied Basic Research Foundation of Guangdong Province
- Sanming Project of Medicine in Shenzen Municipality
- Science, Technology and Innovation Commission of Shenzhen Municipality
- National Natural Science Foundation of China
- Shenzhen University
- Shenzhen-Hong Kong Science and Technology Innovation Cooperation Zone
Zitieren
APA
Fang, X., Gong, R., Yang, D., Li, C., Zhang, Y., Wang, Y., Nie, G., Li, M., Peng, X., & Zhang, B. (2024). NIR-II Light-Driven Genetically Engineered Exosome Nanocatalysts for Efficient Phototherapy against Glioblastoma. Journal of the American Chemical Society, 146(22), 15251-15263. https://doi.org/10.1021/jacs.4c02530
Vancouver
Fang X, Gong R, Yang D, Li C, Zhang Y, Wang Y, et al. NIR-II Light-Driven Genetically Engineered Exosome Nanocatalysts for Efficient Phototherapy against Glioblastoma. Journal of the American Chemical Society. 2024;146(22):15251-15263. doi:10.1021/jacs.4c02530
BibTeX
@article{Fang2024,
author = {Fang, Xueyang and Gong, Rui and Yang, Decai and Li, Chenxi and Zhang, Yuanyuan and Wang, Yan and Nie, Guohui and Li, Mingle and Peng, Xiaojun and Zhang, Bin},
title = {NIR-II Light-Driven Genetically Engineered Exosome Nanocatalysts for Efficient Phototherapy against Glioblastoma},
journal = {Journal of the American Chemical Society},
year = {2024},
volume = {146},
number = {22},
pages = {15251--15263},
doi = {10.1021/jacs.4c02530}
}
EUVIMED